日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Vision-Enabled AI scribes reduce omissions in clinical conversations: evidence from simulated medication histories

视觉辅助型人工智能记录员可减少临床对话中的遗漏:来自模拟用药史的证据

Menz, Bradley D; Scarfo, Nicholas L; Modi, Natansh D; Cornelisse, Erik; Li, Lee X; Tan, Jin Quan Eugene; Gandhi, Jimit; Maher, Dorsa; Kousa, Dib; Daniel, Kezia; Menon, Vidya; Bacchi, Stephen; McKinnon, Ross A; Wiese, Michael D; Rowland, Andrew; Sorich, Michael J; Hopkins, Ashley M

Evaluation of hyperprogressive disease with atezolizumab plus bevacizumab for hepatocellular carcinoma: A secondary analysis of the IMbrave150 trial

对使用阿特珠单抗联合贝伐珠单抗治疗肝细胞癌超进展疾病的评估:IMbrave150试验的二次分析

Gao, Yuan; Cheng, Ann-Lii; Li, Lee X; Parent, Natalie; Kichenadasse, Ganessan; Karapetis, Christos S; Rowland, Andrew; Hopkins, Ashley M; Sorich, Michael J

Tumour Mutational Burden and Immune Checkpoint Inhibitor Response in Non-small Cell Lung Cancer: A Continuous Modelling Approach

非小细胞肺癌中肿瘤突变负荷与免疫检查点抑制剂反应:一种连续建模方法

Sorich, Michael J; Manning-Bennett, Arkady T; Li, Lee X; Shahnam, Adel; Kichenadasse, Ganessan; Karapetis, Christos S; Abuhelwa, Ahmad Y; McKinnon, Ross A; Rowland, Andrew; Hopkins, Ashley M

Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast Cancer

常用伴随用药与乳腺癌患者生存率和不良事件结局的关联

Modi, Natansh D; Abuhelwa, Ahmad Y; Kuderer, Nicole M; Li, Lee X; Lyman, Gary H; Koczwara, Bogda; Kichenadasse, Ganessan; Selth, Luke A; Rickard, Ceara; Haseloff, Mark; Vitry, Agnes; Woodman, Richard; Logan, Jessica M; Ng, Huah Shin; Wiese, Michael D; McKinnon, Ross A; Rowland, Andrew; Sorich, Michael J; Hopkins, Ashley M

The state of individual participant data sharing for the highest-revenue medicines

高收益药物的个体参与者数据共享现状

Modi, Natansh D; Li, Lee X; Logan, Jessica M; Wiese, Michael D; Abuhelwa, Ahmad Y; McKinnon, Ross A; Rowland, Andrew; Sorich, Michael J; Hopkins, Ashley M

Clostridial Prosthetic Joint Infections: A Review of the Literature, Management Strategies, and Outcomes

梭菌性假体关节感染:文献综述、治疗策略和预后

Panayiotou, Dimitris; Drazich-Taylor, Stuart; Ting, Lee X; Hussain, Abid

A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials

晚期非小细胞肺癌中BMI与化疗免疫疗法疗效之间缺乏关联:IMpower150和IMpower130临床试验的二次分析

Li, Lee X; Socinski, Mark A; Kichenadasse, Ganessan; Karapetis, Christos S; Shahnam, Adel; McKinnon, Ross A; Rowland, Andrew; Hopkins, Ashley M; Sorich, Michael J

Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials

一线化疗免疫疗法治疗晚期非小细胞肺癌超进展风险低:7项临床试验的汇总分析

Li, Lee X; Cappuzzo, Federico; Matos, Ignacio; Socinski, Mark A; Hopkins, Ashley M; Sorich, Michael J

Attributable Length of Stay, Mortality Risk, and Costs of Bacterial Health Care-Associated Infections in Australia: A Retrospective Case-cohort Study

澳大利亚细菌性医疗相关感染的住院时长、死亡风险和成本:一项回顾性病例队列研究

Lee, X J; Stewardson, A J; Worth, L J; Graves, N; Wozniak, T M

Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer

对化疗耐药的晚期宫颈癌患者,在接受帕博利珠单抗单药治疗后,进行肿瘤分子谱分析,以区分应答者和无应答者。

Ngoi, N Y L; Heong, V; Lee, X W; Huang, Y Q; Thian, Y L; Choo, B A; Lim, D; Lim, Y W; Lim, S E; Ilancheran, A; Soong, R; Tan, D S P